Back to Top Skip to main content Skip to sub-navigation

DoD leadership updates Pentagon on COVID-19 testing capabilities

Image of Air Force Maj. Gen. (Dr.) Lee Payne speaking, with Pentagon sign behind him Air Force Maj. Gen. (Dr.) Lee Payne, the Defense Health Agency assistant director for Combat Support, joined other Department of Defense leaders to update media about DoD’s COVID-19 testing capabilities during a media presser at the Pentagon July 30. (DoD Photo by Marvin Lynchard)

Recommended Content:

Coronavirus

Testing serves as a vital step in managing COVID-19-related risks to the military and the nation. Air Force Maj. Gen. (Dr.) Lee Payne, the Defense Health Agency’s assistant director for Combat Support, joined other Department of Defense leaders to update media about DoD’s testing capabilities during the COVID-19 pandemic. The officials briefed the media at the Pentagon in Arlington, Virginia, July 30.

The Department of Defense created the COVID-19 Lab Testing Task Force in April 2020 to address screening, surveillance, and diagnostic testing of DoD personnel. DoD selected Payne to lead this effort. The collaborative Testing Task Force has made strides in testing efforts, certifying over 125 DoD labs around the globe that are capable of conducting more than 200,000 COVID-19 tests per week. DoD successfully conducted over 540,000 COVID-19 tests since January, currently completing 50,000 to 60,000 tests a week.

“This has been a coordinated achievement, together with the Joint Staff, the military departments, and the combatant commands,” Payne said. “We’ve all come together to solve this complex problem set.”

Weekly testing for active-duty service members also increased fivefold in the past three months. Air Force Brig. Gen. (Dr.) Paul Friedrichs, Joint Staff surgeon, said confirmed cases in the military are still slightly below the U.S. average for most age groups. One exception is for the 18-24 age range. Friedrichs explained that this number results from increased testing of military recruits before and after basic training. Friedrichs praised the Testing Task Force and local commands for making these tests possible.

"We think that this is a reflection of our commitment to the [Defense Secretary Dr. Mark T. Esper's] first priority of reducing risk to the force and protecting them as they go through performing their duties to protect and defend our nation," Friedrichs said.

A part of keeping the force and civilians safe includes recognizing service members and patients who may be asymptomatic to COVID-19, but still have the antibodies. Patients who are pursuing elective surgery and active-duty service members are also screened for the disease. Some patients also volunteer to come to military medical treatment facilities to be screened for symptoms.

“The good thing about asymptomatic screening is that we are, in essence, screening the population, so we are finding people who don’t know that they have the disease. We’re isolating them. We’re doing contact tracing on those folks,” Payne said. “We’re doing that screening for mission readiness, but it also has the added benefit of reducing disease in the population.”

DoD continues to reduce risk by searching for new approaches to meet diagnostic testing demands. Payne shared goals to expand the number of available tests, innovate new technologies, and improve access to these testing mechanisms. New approaches include pooled testing and new technologies like point-of-care antigen tests and oral swab testing.

Payne noted that testing is only one part of the DoD’s risk reduction strategy. Public health measures like social distancing, restriction of movement for active-duty service members, and use of facial cloth coverings in public also play a role in managing risk.

“We are confident that the consistent use of broad spectrum risk reduction measures across the force are making and will continue to make a difference in controlling the spread of the virus,” Payne said.

Friedrichs agreed, stating that “both the individual and the collective commitment to those basic public health measures … while not necessarily high-tech, are incredibly effective. We are grateful for the support from everyone who’s embraced them in order to reduce risk to the force and to the mission.”

Payne acknowledged that the fight against COVID-19 is still not over. Public health guidance is updated regularly to reflect new information about the novel coronavirus. DoD continues to expand testing capabilities, with the MHS contributing through research, development, and medical care for service members and their families.

“We continue to learn new things about this disease each and every day,” Payne said, “but we are agile, and we adapt our strategy to protect our people. I am confident that we are doing everything we can … to enable commanders to keep their forces mission-ready, and to keep the DoD family safe and healthy.”

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus
Showing results 1 - 10 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.